期刊
INTERNATIONAL JOURNAL OF CANCER
卷 125, 期 4, 页码 868-878出版社
WILEY
DOI: 10.1002/ijc.24452
关键词
CD25+; T-REG; Min mice; prostate cancer
类别
资金
- National Institutes of Health [R01CA108854, P30ES02109, T32RR07036]
Chronic inflammation contributes to the development of prostate cancer in humans. Here, we shove that male Apc(Min/+) mice also develop prostate carcinoma with increasing age, mimicking that seen in humans in their 5th or 6th decade of life. Proinflammatory cytokines were significantly linked with cancer and increasing age in our mouse model; however, prostate and bowel tissues lacked evidence of inflammatory cell infiltrates other than mast cells. Lymphocytes protected against cancer, and protection from prostate cancer resided in antiinflammatory CD4(+)CD25(+) regulatory (T-REG) cells that downregulated inflammatory cytokines. Supplementation with syngeneic T-REG cells collected from wild-type mice reduced the levels of interleukin (IL)-6 (p < 0.05) and IL-9 (p < 0.001) and lowered prostate cancer risk (p < 0.05). Depletion of CD25(+) cells in 2-month-old animals increased the expression of IL-6 (p < 0.005) within prostate and increased the frequency of high-grade prostatic intraepithelial neoplasia (p < 0.05) and microinvasive prostatic carcinoma (p < 0.05) in dorsolateral prostate. Depletion of CD25(+) cells in young animals also increased the frequency of intestinal cancer in Min mice. Taken together, chronically elevated proinflammatory cytokines promoted carcinoma in Apc(Min/+) mice. T-REG lymphocytes downregulated inflatnmation-associated carcinogenic processes and contributed to immune and epithelial homeostasis. (C) 2009 UICC
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据